Clinical characteristics in 48 patients with type 2 diabetes mellitusa.
Control | DN | DN + BLC | |
---|---|---|---|
Number | 16 | 16 | 16 |
Male/female | 3/13 | 4/12 | 4/12 |
Age (years) | 59 ± 7 | 60 ± 6 | 61 ± 6 |
BMI (kg m−2) | 28 ± 4 | 28 ± 4 | 28 ± 4 |
Creatinine (mg dL−1) | 0.8 ± 0.1 | 0.9 ± 0.1 | 0.8 ± 0.1 |
Systolic BP (mmHg) | 119 ± 10 | 127 ± 19 | 124 ± 17 |
Diastolic BP (mmHg) | 74 ± 11 | 79 ± 13 | 77 ± 12 |
HbA1c (%) | 6.2 ± 0.8 | 6.7 ± 1.1 | 6.5 ± 1.0 |
Diabetes duration (years) | 10 ± 3 | 15 ± 4 | 14 ± 3 |
eGFR (mL min−1) | 93 ± 21 | 79 ± 20b | 88 ± 23 |
Albuminuria (mg L−1) | 0.7 ± 0.4 | 8 ± 5b | 4 ± 3c |
Urine ACR (mg g−1) | 5 ± 2 | 108 ± 46b | 44 ± 22c |
DN, diabetic nephropathy; BLC, Bailing capsule; eGFR, estimated glomerular filtration rate. ACR: albumin to creatinine ratio. Data reported as mean ± standard deviation (SD).
Significantly altered compared to control group.
Significantly (p < 0.05) altered compared to DN group.